Abiopharma

News list

Director Low Jook Yuen 🟢 acquired 16.1K shares of BioNexus Gene Lab Corp (BGLC) Transaction Date: Aug 13, 2026 | Filing ID: 000345

Full text

News bot Aug. 14, 2026, 9:16 p.m.
🔍 Low Jook Yuen (Director)

Company: BioNexus Gene Lab Corp (BGLC)

Report Date: 2026-08-13
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 16,129
Detailed Transactions and Holdings:
- Acquired 16,129 shares of Common Stock (Direct)
  Date: 2026-08-13 | Code: A | equity_swap_involved: 0 | shares_owned_after: 17,390.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Represents a fully vested Other Stock-Based Award of 16,129 shares of common stock, no par value, granted on August 13, 2026 under the BioNexus Gene Lab Corp. 2025 Equity Incentive Plan. The award was granted for completed services, for no cash consideration and valued for Plan purposes at $1.55 per share (the Nasdaq closing price on August 12, 2026).